KeyCorp Cuts HCA Healthcare (NYSE:HCA) Price Target to $370.00

HCA Healthcare (NYSE:HCA) had its target price trimmed by KeyCorp from $420.00 to $370.00 in a report published on Tuesday,Benzinga reports. The brokerage currently has an overweight rating on the stock.

Other equities research analysts also recently issued reports about the company. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their target price for the stock from $400.00 to $320.00 in a report on Monday, November 25th. Truist Financial cut their price target on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday. Finally, Barclays cut their target price on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research note on Friday, November 8th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $385.27.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $311.19 on Tuesday. The company’s 50-day simple moving average is $322.73 and its 200-day simple moving average is $353.88. HCA Healthcare has a one year low of $276.50 and a one year high of $417.14. The stock has a market capitalization of $78.82 billion, a price-to-earnings ratio of 13.97, a PEG ratio of 1.21 and a beta of 1.64. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Friday, December 13th were paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.85%. The ex-dividend date of this dividend was Friday, December 13th. HCA Healthcare’s dividend payout ratio is presently 11.85%.

Insider Buying and Selling

In other news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On HCA Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Benjamin F. Edwards & Company Inc. acquired a new position in HCA Healthcare during the second quarter valued at $33,000. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at about $39,000. Canoe Financial LP purchased a new position in HCA Healthcare during the third quarter valued at approximately $41,000. Capital Performance Advisors LLP purchased a new stake in HCA Healthcare in the 3rd quarter worth approximately $41,000. Finally, Northwest Investment Counselors LLC acquired a new position in shares of HCA Healthcare in the third quarter worth $44,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.